Showing results (221-230 of 475) with videos related to
Sort By:
Pageof 48
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)Y Zhang, R B Rothman, C M Dersch, et al.Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.Molecular Pharmacology|April 1, 1991
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935S P Berger, R E Martenson, P Laing, et al.Life Sciences|January 1, 1991
Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptorsH Diaz-Arauzo, K F Koehler, T J Hagen, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|October 29, 1998
Identification of quinine metabolites in urine after oral dosing in humansP Bannon, P Yu, J M Cook, et al.Life Sciences|December 14, 1987
Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylatorL D Snell, K M Johnson, S J Yi, et al.Annals of the New York Academy of Sciences|January 29, 2005
A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behaviorC L Robison, J L Meyerhoff, G A Saviolakis, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1991
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic studyM Herkenham, A B Lynn, M R Johnson, et al.Drug Design and Discovery|May 12, 2000
Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activationB A Berglund, P R Fleming, K C Rice, et al.Pageof 48